Good evening :)
Place Order
Add to Watchlist

Lactose (India) Ltd

LACTOSE

Lactose (India) Ltd

LACTOSE
Health CarePharmaceuticals
SmallcapWith a market cap of ₹216 cr, stock is ranked 2,277
High RiskStock is 4.43x as volatile as Nifty
172.900.52% (-0.90)
172.900.52% (-0.90)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹216 cr, stock is ranked 2,277
High RiskStock is 4.43x as volatile as Nifty
Scorecard

Performance

High

The creamy layer - amongst the top performing stocks

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹216 cr, stock is ranked 2,277
High RiskStock is 4.43x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
31.825.33
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
44.495.960.56%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Lactose India Limited is a pharmaceutical company engaged in the business of manufacturing pharmaceutical products. The Company is principally engaged in manufacturing of lactose monohydrate

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 22.89%, vs industry avg of 8.96%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.02% to 0.03%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 56.6%, vs industry avg of 15.15%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue35.7036.5231.7641.0340.3535.2746.5266.53115.01115.01
Raw Materialssubtract10.046.245.737.707.044.657.1835.6594.8994.89
Power & Fuel Costsubtract4.635.425.326.246.305.846.897.09
Employee Costsubtract7.038.479.0711.1711.8810.6312.2512.24
Selling & Administrative Expensessubtract2.472.672.812.902.502.802.894.08
Operating & Other expensessubtract-0.121.472.562.993.064.824.47-4.71
Depreciation/Amortizationsubtract3.343.413.593.603.914.364.564.695.225.22
Interest & Other Itemssubtract4.424.465.465.355.565.455.126.045.245.23
Taxes & Other Itemssubtract1.081.58-1.440.360.03-0.790.720.262.882.88
EPS3.263.02-1.360.710.07-2.302.030.955.395.39
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Lactose (India) Ltd31.865.33
Sun Pharmaceutical Industries Ltd39.305.610.86%
Cipla Ltd29.115.060.87%
Zydus Lifesciences Ltd29.845.210.26%

Price Comparison

Compare LACTOSE with any stock or ETF
Compare LACTOSE with any stock or ETF
LACTOSE
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding

Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding53.65%0.00%0.62%0.00%45.74%

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Shareholding History

MarJunSepDec '23MarJun0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

LACTOSE has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time